Staging Imaging in Cutaneous Melanoma at Clinical Stage II: Timing and Necessity
Source: Physician’s Weekly, March 2023
The following is a summary of “Timing and necessity of staging imaging in clinical stage II cutaneous melanoma: Cost-effectiveness and clinical decision analysis,” published in the JANUARY 2023 issue of Surgery by Khan, et al.
Although not recommended by National Comprehensive Cancer Network (NCCN) recommendations for clinical stage II melanoma, preoperative imaging was nonetheless often used in clinical practice.
A retrospective analysis was done by researchers on patients who presented with stage II cutaneous melanoma between 2007 and 2019. To comprehend appropriate practice patterns in handling stage II melanoma, a clinical decision analysis using cost data was created, utilizing pre-versus selective post-operative imaging as the initial decision node.